Panagiotis Kottaridis

6.4k total citations · 1 hit paper
59 papers, 3.7k citations indexed

About

Panagiotis Kottaridis is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Panagiotis Kottaridis has authored 59 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 17 papers in Genetics and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Panagiotis Kottaridis's work include Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (15 papers). Panagiotis Kottaridis is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Acute Lymphoblastic Leukemia research (15 papers). Panagiotis Kottaridis collaborates with scholars based in United Kingdom, United States and Denmark. Panagiotis Kottaridis's co-authors include David C. Linch, Rosemary E. Gale, Anthony H. Goldstone, David Bowen, Stephen E. Langabeer, Marion E. Frew, Keith Wheatley, Alan K. Burnett, Stephen Mackinnon and G Harrison and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Panagiotis Kottaridis

55 papers receiving 3.6k citations

Hit Papers

The presence of a FLT3 internal tandem duplication in pat... 2001 2026 2009 2017 2001 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
    2001 1.2k citations Panagiotis Kottaridis, Rosemary E. Gale et al. Blood profile →

Peers

Panagiotis Kottaridis
Jean‐Michel Cayuela France
Francis Ayuk Germany
Giuseppe Bandini Italy
Tatjana Zabelina Germany
RE Champlin United States
DC Arthur United States
Yang O. Huh United States
AB Deisseroth United States
Christine Wolschke Germany
Camille N. Abboud United States
Jean‐Michel Cayuela France
Panagiotis Kottaridis
Citations per year, relative to Panagiotis Kottaridis Panagiotis Kottaridis (= 1×) peers Jean‐Michel Cayuela

Countries citing papers authored by Panagiotis Kottaridis

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Kottaridis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Kottaridis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Kottaridis more than expected).

Fields of papers citing papers by Panagiotis Kottaridis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Kottaridis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Kottaridis. The network helps show where Panagiotis Kottaridis may publish in the future.

Co-authorship network of co-authors of Panagiotis Kottaridis

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Kottaridis. A scholar is included among the top collaborators of Panagiotis Kottaridis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Kottaridis. Panagiotis Kottaridis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, Nigel H., Jad Othman, Oliver Cumming, et al.. (2025). Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3 -mutated AML. Blood Advances. 9(24). 6455–6466.
2.
Mullish, Benjamin H., Andrew J. Innes, Lauren A. Roberts, et al.. (2024). Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial. BMJ Open. 14(12). e093120–e093120. 1 indexed citations
3.
Othman, Jad, Nicola Potter, Adam Ivey, et al.. (2024). Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood. 143(19). 1931–1936. 33 indexed citations
4.
Marzolini, Maria A. V., Irfan Kayani, Ben Carpenter, et al.. (2024). The Effect of the Pre‐Transplant Disease Status on the Outcome for Recipients of T‐Cell Depleted Allogeneic Haematopoietic Stem Cell Transplants for Large B Cell Lymphomas. European Journal Of Haematology. 114(3). 545–555.
5.
6.
7.
Kottaridis, Panagiotis, Janet North, Chloë Marden, et al.. (2015). Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial. PLoS ONE. 10(6). e0123416–e0123416. 49 indexed citations
8.
Katodritou, Eirini, Evangelos Terpos, Janet North, et al.. (2011). Tumor‐primed natural killer cells from patients with multiple myeloma lyse autologous, NK‐resistant, bone marrow‐derived malignant plasma cells. American Journal of Hematology. 86(12). 967–973. 15 indexed citations
9.
Knight, Andrea, J. Alejandro Madrigal, Sarah Grace, et al.. (2010). The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. 116(12). 2164–2172. 159 indexed citations
10.
Knight, Andrea, et al.. (2010). The role of V delta 2-negative gamma delta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. UCL Discovery (University College London). 6 indexed citations
11.
12.
Coghlan, Gerry, Clive Handler, & Panagiotis Kottaridis. (2007). Cardiac assessment of patients for haematopoietic stem cell transplantation. Best Practice & Research Clinical Haematology. 20(2). 247–263. 20 indexed citations
13.
Fielding, A, Anne Parker, Effie Liakopoulou, et al.. (2006). Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis. UCL Discovery (University College London). 1 indexed citations
14.
Papageorgiou, Sotirios G., Anna Castleton, Adrian Bloor, & Panagiotis Kottaridis. (2006). Allogeneic stem cell transplantation as treatment for myelofibrosis. Bone Marrow Transplantation. 38(11). 721–727. 10 indexed citations
15.
Grimwade, David, R P Gale, Robert K. Hills, et al.. (2003). The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia.. Blood. 102(11). 3 indexed citations
16.
Kottaridis, Panagiotis, Rosemary E. Gale, & David C. Linch. (2003). Flt3 mutations and leukaemia. British Journal of Haematology. 122(4). 523–538. 112 indexed citations
17.
Morris, Emma, Charles Craddock, D Milligan, et al.. (2002). Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).. UCL Discovery (University College London). 2 indexed citations
18.
Chatterjee, Ratna, Panagiotis Kottaridis, Hugh H. G. McGarrigle, & Anthony H. Goldstone. (2001). Reversal of Fludarabine Induced Testicular Damage in a Patient with Chronic Lymphocytic Leukaemia (CLL), by Suppression of Pituitary-Testicular Axis Using Gonadotrophin Releasing Hormone (GnRH). Leukemia & lymphoma. 41(1-2). 213–215. 6 indexed citations
19.
Kottaridis, Panagiotis, Marion E. Frew, G Harrison, et al.. (2000). The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.. Blood. 96. 7 indexed citations
20.
Kottaridis, Panagiotis, Julie M. Vose, David C. Linch, et al.. (1998). Allogeneic transplantation following failure of autologous transplantation for lymphoma.. UCL Discovery (University College London). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Michel Cayuela Breakdown of academic impact, for papers by Francis Ayuk Breakdown of academic impact, for papers by Giuseppe Bandini Breakdown of academic impact, for papers by Tatjana Zabelina Breakdown of academic impact, for papers by RE Champlin Breakdown of academic impact, for papers by DC Arthur Breakdown of academic impact, for papers by Yang O. Huh Breakdown of academic impact, for papers by AB Deisseroth Breakdown of academic impact, for papers by Christine Wolschke Breakdown of academic impact, for papers by Camille N. Abboud
Rankless by CCL
2026